A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung

Lo M. Sosinski(Michigan United), Robert A. Quinn(Michigan State University), Lydia-Ann J. Ghuneim(Michigan State University), Douglas V. Guzior(DiscoveryBioMed (United States)), Marc McClelland(Spectrum Health), Kerri A. Neugebauer(Michigan State University), Alicia Castillo-Bahena(Spectrum Health), Ryan Thomas(Michigan State University), Jenna Mielke(University of California, San Diego), Doug Conrad(University of California, San Diego), Christian Martin(Secretaría Nacional de Ciencia, Tecnología e Innovación)
Journal of Cystic Fibrosis
November 22, 2021
Cited by 71


Related Papers